Moreover, while drug resistance imposes a failure that reversed the initial response to chemotherapy in patients with SCLC, here we have shown that anti-tumor activity of BGA002 against MYCN-related SCLC occurs independently of multidrug resistance. The gene discussed is MYCN; the disease is small cell lung carcinoma.